Westlake: 512-327-5337
Cedar Park: (512) 327-5337
Motiva® implants represent the most advanced breast implant engineering currently available — designed to move naturally with the body, minimize rippling, and provide long-term safety transparency. Hall Plastic Surgery is one of a limited number of Austin-area practices where a board-certified plastic surgeon performs Motiva augmentation personally. Appointments at Westlake and Cedar Park.
Motiva breast implants are a next-generation silicone breast implant system engineered by Establishment Labs (Costa Rica) with a focus on biomechanical performance — specifically, how the implant moves, feels, and behaves in the body over time. They are differentiated from conventional implants by a proprietary progressive gel fill, an ultra-low-friction surface technology, and a core architecture designed to minimize the mechanical forces that contribute to implant complications. Available in both round and shaped configurations. Approved for use in more than 80 countries.
The key difference between Motiva implants and conventional silicone implants is not simply material — it is engineering philosophy. Traditional silicone implants are designed to hold a shape and maintain volume. Motiva implants are designed around a different question: how does the implant behave as the patient moves, bends, sits, and sleeps? The answer led to a gel formulation and core structure that responds dynamically to gravitational forces and body position, producing results that closely mimic natural breast tissue mechanics rather than a static prosthetic feel.
Dr. Hall offers Motiva alongside Allergan implants — a deliberate choice that reflects the reality that the best implant is the one that fits the individual patient’s anatomy, goals, and priorities. Some patients are ideal Motiva candidates; others are better served by Allergan’s broader documented track record. Dr. Hall presents both options at consultation and makes a recommendation based on your specific case — not on which system has higher margins or manufacturer incentives.
Hall Plastic Surgery — Westlake, Austin TX · Motiva® breast augmentation by Dr. Jeffrey Hall
Motiva’s engineering differentiators are real and clinically meaningful — but they are also frequently overstated in marketing. Here is an accurate, plain-language breakdown of what each technology does and why it matters for patients.
The gel, barrier layers, and shell are engineered as a unified structural system — rather than a gel core simply encased in a shell. This reduces internal gel migration toward the implant wall, which is a primary mechanical contributor to visible rippling and wrinkling. The result is more stable contour over time, particularly in patients with thin overlying tissue.
Motiva uses a cohesive gel with a progressive density gradient — softer at the center, firmer toward the periphery. This allows the implant to deform naturally under compression (like natural breast tissue) while maintaining shape at rest. Most patients and partners describe the feel as indistinguishable from natural tissue in a way that older-generation implants do not replicate.
The Ergonomix® implant is round when the patient is upright — where gravity pulls tissue downward — and adopts a more teardrop profile when the patient is lying down. This gravity-responsive behavior is produced by the gel’s progressive formulation rather than a shaped shell, which means it does not carry the rotation risk associated with anatomical shaped implants.
Motiva’s shell surface is among the smoothest available in any implant system, with a NanoSurface® texture measured in nanometers rather than micrometers. Ultra-low surface friction reduces the mechanical irritation to surrounding tissue that has been theorized as a contributing factor in capsular contracture formation. It also avoids the macro-textured surface associated with BIA-ALCL risk.
BluSeal® is a colored barrier layer integrated into the outer shell. Its purpose is visual — during surgery, the surgeon can immediately identify any micro-perforation of the shell by the presence of the blue layer at the surface, rather than relying on feel or post-operative imaging. It provides an intraoperative safety check that does not exist in conventional implant systems.
Each Motiva implant contains an embedded RFID/NFC chip that can be read by an external scanner without radiation. This allows the surgeon, patient, or radiologist to identify the exact implant model, lot number, and serial number at any point post-implantation — without surgery or imaging. Clinically relevant for revision planning and for confirming implant identity in patients who lose their implant card.
Preservé® (Breast Tissue Preservation) is an advanced, less invasive breast augmentation technique — made possible by Motiva’s patented instruments — designed to preserve your natural breast tissue, nipple sensation, and chest muscles. It is a surgical technique, not a different implant, and it is performed with FDA-cleared Motiva SmoothSilk® implants. Dr. Hall is certified in the Preservé technique.
Conventional breast augmentation typically uses electrocautery and a larger incision to create the implant pocket, which can mean more tissue trauma, more inflammation, and a longer recovery. Preservé takes a different path: through a small incision hidden in the inframammary fold, Dr. Hall uses the Motiva® Channel Separator to create a tunnel without cutting through the tissue, then the Motiva® Inflatable Balloon to gently expand a precise pocket sized to your implant. The implant is then placed, leaving the surrounding nerves, ligaments, and breast architecture intact.
Because the technique works with your natural anatomy rather than dividing it, Preservé is best suited to patients undergoing a first-time (primary) breast augmentation — or a first-time augmentation combined with a lift — who want a natural, proportionate result and a smoother recovery. It is generally not the right approach for complex revision surgery, very large implant volumes, or patients with minimal soft-tissue coverage. Dr. Hall will tell you honestly at consultation whether Preservé fits your anatomy and goals, or whether a conventional approach would serve you better.
Note: In the United States, the Preservé technique is performed using the FDA-registered Motiva Channel Separator and Inflatable Balloon together with FDA-cleared Motiva SmoothSilk® implants. Individual candidacy, technique, and results are determined by Dr. Hall based on your anatomy.
Dr. Hall offers both systems because both are clinically appropriate depending on the patient. Neither is objectively superior. The right choice depends on your anatomy, tissue coverage, goals, and how you weight the specific trade-offs between systems. This is the comparison as Dr. Hall presents it at consultation.
Dr. Hall’s clinical position: For patients with thin breast tissue and minimal native coverage — where rippling is a higher risk — Motiva’s TrueMonobloc® core makes it the technically superior choice. For patients who prioritize the longest available post-market safety record, or who specifically want U.S. FDA-approved silicone, Allergan is the more appropriate recommendation. For most patients, both systems are excellent and the difference comes down to anatomy, priorities, and a direct conversation at consultation.
Motiva implants are not the right choice for every breast augmentation patient — and Dr. Hall will tell you if they’re not. The following patient profiles represent those who most benefit from Motiva’s specific engineering advantages over conventional implant systems.
Motiva is particularly well-suited for:
Motiva may be less critical — though still an excellent option — for patients with substantial native breast tissue coverage (where implant-specific feel differences are less perceptible) or for patients whose primary decision criteria is the longest available FDA post-market surveillance dataset, where Allergan holds a clear advantage.
Dr. Hall evaluates tissue coverage, existing volume, skin quality, and your stated priorities at consultation and makes a direct recommendation — including when the implant system difference will not meaningfully affect your specific outcome.
Implant selection is not a catalog decision. It is a clinical recommendation based on your anatomy, tissue coverage, desired outcome, and an honest comparison of what each system actually offers for your specific case. Here is how that process works at Hall Plastic Surgery.
Dr. Hall evaluates your native breast tissue volume, skin thickness, and existing coverage at physical examination. Thin-tissue patients have meaningfully different implant selection criteria than patients with substantial native tissue — rippling visibility, edge definition, and the perceptible feel difference between implant systems are all tissue-dependent variables. This assessment comes before any implant recommendation.
Dr. Hall asks directly: what matters most to you — the most natural feel available, the longest safety track record, saline as an option, or something else? Patients who have not thought about this are walked through what actually differentiates the systems in plain language. The goal is a decision based on what you actually care about, not on brand recognition or what the surgeon finds easiest to work with.
Motiva is available in the Ergonomix® round range across multiple profiles. Sizing uses your base width — the measured width of your breast footprint — as the primary constraint, combined with your volume goals and the physical sizer experience at consultation. Dr. Hall does not select implants by cup size; he selects by anatomical fit and volume displacement relative to your chest wall dimensions.
Motiva implants perform well in both subglandular and submuscular (dual-plane) positions. For thin-tissue patients — the profile where Motiva’s advantages are most pronounced — Dr. Hall typically recommends submuscular or dual-plane placement to maximize coverage and minimize visible rippling risk regardless of implant choice. Placement and implant selection are discussed together because they are interdependent decisions.
Dr. Hall tells you which system he recommends for your anatomy and goals — and why. If the difference between Motiva and Allergan will not meaningfully affect your outcome given your tissue coverage and priorities, he says so. The consultation is not a sales process for either manufacturer’s product. It is a clinical decision made in your interest.
Dr. Hall has been performing breast augmentation in Austin for over 25 years. He is certified by the American Board of Plastic Surgery (ABPS) — continuously since 1997 — and is an active member of the American Society of Plastic Surgeons (ASPS) and the Texas Medical Association.
Hall Plastic Surgery offers Motiva implants because the technology is clinically meaningful for a specific subset of patients — not because it carries higher fees or manufacturer prestige. Dr. Hall’s approach to implant selection is evidence-based and anatomy-specific. He does not recommend Motiva to every augmentation patient any more than he recommends Allergan to every patient. The recommendation matches the patient in front of him.
This matters because the implant system is one of many variables in a breast augmentation outcome. Surgical technique — pocket dissection, hemostasis, implant handling, incision closure — has as much or more impact on final results and complication rates as implant selection does. A technically superior implant placed by an inexperienced surgeon produces worse outcomes than a conventional implant placed by a surgeon with 25+ years of case volume. Dr. Hall’s patients benefit from both: current implant technology and the surgical experience to optimize every technical step of the operation.
4.9★ across 342 verified Google reviews. Read what Austin-area patients say about their breast augmentation experience with Dr. Hall.
Motiva breast implants are a next-generation silicone implant system manufactured by Establishment Labs. They are distinguished from conventional implants by their TrueMonobloc® core architecture (which reduces rippling), progressive gel fill (which produces natural feel and movement), SmoothSilk® NanoSurface® shell (ultra-low friction), and Q Inside Safety Technology® NFC chip (non-invasive implant identification). Available in round Ergonomix® configurations that respond dynamically to gravity and body position.
Motiva implants are approved in more than 80 countries and have substantial published clinical outcome data. In the United States, Motiva’s manufacturer (Establishment Labs) has been in the FDA Pre-Market Approval (PMA) process; the current U.S. regulatory status should be confirmed at consultation. Dr. Hall discusses the regulatory status of both implant systems at consultation so patients can make a fully informed decision. For patients for whom FDA approval is a primary criterion, Allergan’s long-standing full PMA approval may be the more appropriate choice.
Motiva’s progressive gel fill produces a feel that most patients and surgeons describe as the closest to natural breast tissue of any currently available implant. The gel is softer at the center and firmer toward the periphery, which mimics the compressibility of natural glandular tissue. Under adequate tissue coverage, the difference from Allergan may be imperceptible. In thin-tissue patients with limited native coverage, the Motiva gel formulation produces a meaningfully more natural result.
The Ergonomix® is Motiva’s round implant with gravity-responsive behavior. When the patient is upright, the gel distributes toward the lower pole and the implant takes on a slightly teardrop appearance. When the patient lies down, gravity redistributes the gel and the implant appears rounder. This dynamic behavior is produced by the gel formulation — not a shaped shell — which means it does not carry the rotation risk associated with anatomically shaped implants. It produces results that look and move naturally in both static and dynamic positions.
BluSeal® is a colored (blue) barrier layer integrated into the outer shell of Motiva implants. Its clinical purpose is intraoperative safety: if the shell is micro-perforated during handling or implantation, the blue layer becomes visible to the surgeon, providing an immediate visual indicator of shell integrity compromise. This allows the surgeon to identify and address a compromised implant before closing — a safety check that does not exist in conventional clear-shelled implants.
Q Inside Safety Technology® is an embedded RFID/NFC microtransponder chip inside each Motiva implant. It can be read by an external scanner without any radiation, surgery, or imaging. The chip stores the implant model number, serial number, and manufacturer data. Practically, this means a surgeon, patient, or radiologist can identify exactly which implant is in place at any post-operative point — even years later — without requiring the patient to produce their implant card or undergo imaging. Clinically useful for revision planning, rupture investigation, and implant records.
Motiva’s NanoSurface® shell avoids the macro-textured surface associated with Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) risk — a meaningful safety advantage over older textured implant systems that have been withdrawn from some markets. Motiva’s TrueMonobloc® core is designed to reduce mechanical stress that can contribute to gel bleed and capsular contracture. That said, all current implant systems — including Allergan smooth implants — carry very low BIA-ALCL risk. Motiva does not claim to be “safer” than Allergan smooth silicone; it claims specific engineering advantages that may reduce specific risk factors in specific patient profiles.
Dr. Hall’s recommendation is based on three factors: tissue coverage (thin-tissue patients benefit more from Motiva’s engineering), patient priorities (natural feel vs. longest FDA track record), and anatomy-specific considerations like placement approach and desired profile. He presents both systems at consultation with an honest assessment of what differentiates them in the context of your specific anatomy — and makes a direct recommendation. He does not recommend Motiva by default or steer patients toward either system based on factors other than clinical fit.
Yes. Motiva implants can be placed as the breast augmentation component of a Mommy Makeover combination procedure. The implant choice — Motiva or Allergan — is made at consultation based on the same criteria as a standalone augmentation: tissue coverage, goals, and patient priorities. The combination surgery itself — what is done with the abdomen and whether a breast lift is added — is a separate discussion from implant selection.
Yes. Patient financing is available through several partners, including 0% APR options for qualified applicants. Visit the financing page for current options and to apply online. Motiva implant cost is discussed at consultation alongside total procedure pricing, which includes surgeon fee, anesthesia, facility, and implants.
Motiva implants are not designed with a fixed lifespan or replacement schedule. The published outcome data shows very high durability — consistent with or exceeding conventional implant longevity — but the long-term follow-up dataset for Motiva does not yet match the 20+ year data available for Allergan. Many patients keep their implants for 15–20+ years without complication. Replacement is indicated if rupture occurs, if capsular contracture develops requiring surgical correction, or if the patient’s aesthetic goals change.
Preservé® is a surgical technique, not a different implant. It is an advanced, less invasive method of placing a Motiva SmoothSilk® implant that preserves your natural breast tissue, nipple sensation, and chest muscles. Instead of cutting through tissue with cautery, Dr. Hall uses the Motiva® Channel Separator and Inflatable Balloon to create the implant pocket through a small incision hidden in the breast fold. Dr. Hall is certified in the Preservé technique and will determine at consultation whether it fits your anatomy and goals.
Preservé is best suited to patients undergoing a first-time (primary) breast augmentation — or a first augmentation combined with a lift — who want a natural, proportionate result and a smoother recovery. It is generally not appropriate for complex revision surgery, very large implant volumes, or patients with minimal soft-tissue coverage. Dr. Hall evaluates candidacy at your consultation and is transparent about whether Preservé or a conventional approach will best support your goals and long-term result.
Motiva implants are one option within a broader breast augmentation decision. These related pages provide context for patients evaluating the full picture.
300 Beardsley Lane, Bldg C Ste 101
Austin, TX 78746
Mon–Thu: 9:00 AM – 5:00 PM
Fri: 9:00 AM – 3:00 PM
Accredited on-site surgical facility — all Motiva procedures performed here
Call (512) 327-5337301 Denali Pass Dr Suite 6
Cedar Park, TX 78613
Mon, Tue, Wed, Fri: 9:00 AM – 5:00 PM
Thu: By appointment
Consultations & medspa services — surgery at Westlake
Call (512) 327-5337Consultations are in-person and with Dr. Hall personally. He’ll examine your anatomy, walk you through Motiva and Allergan in the context of your specific tissue coverage and goals, and give you a direct recommendation — including an honest assessment of when the system difference will or won’t matter for your outcome. Appointments at Westlake and Cedar Park.